Image-guided surgery and light therapy for colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a special dye that helps surgeons see tumors more clearly during surgery, followed by a light therapy to destroy any remaining cancer cells. It is for people with advanced or returning colorectal cancer who are already scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced or returning colorectal cancer and are planning to have surgery.
- You are able to have a CT scan and MRI.
- You are willing to use birth control if there is any chance of pregnancy.
- You do not have porphyria or a known allergy to porphyrin compounds.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special fluorescent dye during laparoscopic surgery helps surgeons better see and remove rectal or sigmoid colon cancer. The goal is to see if this technique makes the surgery more precise and possibly improves outcomes.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial is testing three different combinations of existing and new drugs for advanced or metastatic colorectal cancer that hasn't improved with standard treatments or has spread to the liver. The goal is to see which combination works best and is safe for patients like you.
This trial tests treatments given before surgery for colorectal cancer that has not spread. The goal is to shrink the tumor and improve surgical outcomes. It may be an option for patients with stage II or III colorectal cancer who have not had prior treatment.
This trial combines a special type of radiation, immunotherapy, a targeted blood-vessel drug, and a chemotherapy pill for patients whose colorectal cancer has continued to grow after two prior treatments. The hope is that this combination can shrink tumors or slow down the cancer better than current options.
This trial tests a new way to destroy lung tumors using a light-activated drug (5-ALA) and a special light during a bronchoscopy (a tube placed into the lungs). It may be an option if standard treatments have not worked or are not suitable for you.
Hear when a new Locally Advanced Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.